Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2010

Nov 1, 2010

6990_dirs_2010-11-01_900d5a1f-a52c-46d2-b84e-dbf45d33702e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2010-10-28

Reporting Person: GERMAIN MARK (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-10-28 Common Stock A 40000 Acquired 154348 Direct

Footnotes

F1: The shares vest as follows: 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3
months.